ClinConnect ClinConnect Logo
Search / Trial NCT06317935

The Effect of Virtual Reality Application on Independence and Hand Functions in Daily Life in Children With CP

Launched by HACETTEPE UNIVERSITY · Mar 12, 2024

Trial Information

Current as of June 27, 2025

Not yet recruiting

Keywords

Virtual Reality Upper Extremity Hemiplegic Cerebral Palsy

ClinConnect Summary

This clinical trial is studying how virtual reality (VR) programs can help children with hemiplegic cerebral palsy improve their independence and use of their hands in everyday activities. The researchers want to see if using VR in addition to regular therapy can make a difference in how well these children can function. The trial will involve children aged 6 to 12 who are diagnosed with hemiplegic cerebral palsy and do not have certain physical limitations or recent surgeries.

Children who join the study will be split into two groups. One group will receive VR training along with their usual therapy for three weeks, while the other group will continue with just their regular therapy. Before and after the trial, the researchers will check how well the children's hands work and how independent they feel in daily tasks. This study aims to find out if adding VR can effectively support the rehabilitation process for these children, helping them to gain more skills and confidence in their daily lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • - Having a diagnosis of hemiplegic SP
  • Being between the ages of 6-12
  • Not having any fixed contracture in the upper extremity
  • According to the Modified Ashworth Scale, the upper extremity spasticity value is at the level of 1,1+,2 or 3
  • Being at level I, II or III according to the Gross Motor Function Classification System (GMFCS)
  • Being at level II or III according to the Manual Ability Classification System (MACS)
  • Being at level I, II or III according to the Communication Function Classification System (CFCS)
  • Being within the normal cognitive level according to the Modified Pediatrics Mini Mental Test score
  • Being at level I, II or III according to the Eating and Drinking Ability Classification System (EDACS)
  • Being at level I, II or III according to the Visual Function Classification System for Children with Cerabral Palsy (VFCS)
  • Volunteering to participate in the study
  • Exclusion Criteria:
  • Having botolinum toxin injection within the last 6 months
  • Having undergone a surgical procedure within the last 1 year
  • Fracture, trauma, etc. in the upper extremity. to live

About Hacettepe University

Hacettepe University is a leading research institution in Turkey, renowned for its commitment to advancing medical science and healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, the university supports a wide range of clinical trials aimed at improving patient outcomes and developing new therapeutic approaches. Hacettepe University is dedicated to maintaining the highest ethical standards and regulatory compliance in its research endeavors, fostering an environment that promotes scientific excellence and contributes to the global body of medical knowledge.

Locations

Multiple Locations, Ankara, Turkey

Patients applied

0 patients applied

Trial Officials

Başak Karadağ, MSc

Principal Investigator

Ankara City Hospital Bilkent

Meral Huri, Professor

Study Director

Hacettepe University

Berke Aras, Ass.Prof.

Principal Investigator

Ankara City Hospital Bilkent

Özge Tezen, MD

Study Chair

Ankara City Hospital Bilkent

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported